Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsReceivables RefundsShares Outstanding
Ratios

KalVista Pharmaceuticals (KALV) Long-Term Debt Repayments: 2018-2020

Historic Long-Term Debt Repayments for KalVista Pharmaceuticals (KALV) over the last 2 years, with Apr 2020 value amounting to $1,000.

  • KalVista Pharmaceuticals' Long-Term Debt Repayments fell 98.15% to $1,000 in Q2 2020 from the same period last year, while for Apr 2020 it was $108,000, marking a year-over-year decrease of 48.33%. This contributed to the annual value of $54,000 for FY2020, which is 74.16% down from last year.
  • Per KalVista Pharmaceuticals' latest filing, its Long-Term Debt Repayments stood at $1,000 for Q2 2020, which was up 200.00% from -$1,000 recorded in Q1 2020.
  • In the past 5 years, KalVista Pharmaceuticals' Long-Term Debt Repayments registered a high of $54,000 during Q2 2019, and its lowest value of -$1,000 during Q1 2020.
  • In the last 3 years, KalVista Pharmaceuticals' Long-Term Debt Repayments had a median value of $52,000 in 2018 and averaged $40,556.
  • Per our database at Business Quant, KalVista Pharmaceuticals' Long-Term Debt Repayments increased by 8.00% in 2019 and then tumbled by 101.96% in 2020.
  • Quarterly analysis of 3 years shows KalVista Pharmaceuticals' Long-Term Debt Repayments stood at $52,000 in 2018, then climbed by 3.85% to $54,000 in 2019, then crashed by 98.15% to $1,000 in 2020.
  • Its last three reported values are $1,000 in Q2 2020, -$1,000 for Q1 2020, and $54,000 during Q3 2019.